Zydus Lifesciences gets CDSCO nod to begin Phase II clinical trial of ZYIL1 in Amyotrophic Lateral Sclerosis patients Ruchika Sharma25 Oct 2023 11:16 AM ISTThe Phase II clinical trial will study safety, tolerability, pharmacokinetics and pharmacodynamics in patients with ALS.
Tai Chi may curb Parkinson's disease symptoms and complications for several years Dr. Kamal Kant Kohli25 Oct 2023 10:30 AM ISTTai Chi, the Chinese martial art that involves sequences of very slow controlled movements, may curb the symptoms and complications of Parkinson's...
Golf, walking and Nordic walking may enhance cognitive function in older adults Dr. Kamal Kant Kohli25 Oct 2023 10:15 AM ISTPlaying a single 18-hole round of golf or completing 6 km of either Nordic walking or regular walking may significantly improve immediate cognitive...
How dietary choices play a role in cognitive health of aging women Isra Zaman25 Oct 2023 9:00 AM ISTAs the quest for understanding the relationship between diet and cognitive health continues, a new study sheds light on the potential benefits of the...
High school athletes using steroids more likely to sustain concussion Dr. Kamal Kant Kohli24 Oct 2023 8:00 PM ISTUSA: The use of anabolic steroids in high school athletes is significantly associated with sustaining a concussion, according to a recent study...
Eplontersen feasible gene silencing technique for treating hereditary transthyretin amyloidosis with polyneuropathy: JAMA Medha Baranwal24 Oct 2023 10:00 AM ISTUSA: Eplontersen treatment in adults with hereditary transthyretin (ATTRv) amyloidosis with polyneuropathy resulted in less neuropathy impairment,...
Rare case of Phenytoin induced movement disorders: A report Niveditha Subramani22 Oct 2023 8:00 PM ISTPhenytoin, is a popular drug used as an antiseizure medication sold under the brand name Dilantin. It is useful for the prevention of tonic-clonic...
Researchers design gene therapy that can effectively target glioblastoma Dr. Kamal Kant Kohli21 Oct 2023 9:15 AM ISTGlioblastoma (GBM), an aggressive brain cancer, is notoriously resistant to treatment, with recurrent GBM associated with survival of less than 10...
Fungal entry in the brain may produce changes similar to that seen in Alzheimer's disease Dr. Kamal Kant Kohli21 Oct 2023 5:30 AM ISTUSA: A recent study published in the journal Cell Reports has revealed how the fungus Candida albicans enters the brain, activates two separate...
Topical Tranexamic Acid associated with Reduced Blood Loss in Spine Surgery Dr. Krishna Shah20 Oct 2023 8:00 PM ISTTranexamic acid (TXA) is an antifibrinolytic drug associated with reduced blood loss in a range of surgical specialties, including neurosurgery,...
AI-based model predicts risk of hospital-acquired venous thromboembolism in hospitalized children: VUMC study Dr. Kamal Kant Kohli20 Oct 2023 9:30 AM ISTUSA: Findings from the CLOT trial confirmed the safety and effectiveness of an artificial intelligence (AI) tool for identifying pediatric patients at...
People with COVID-19 infection more likely to develop Guillain-Barre syndrome within six weeks Dr. Kamal Kant Kohli20 Oct 2023 9:00 AM ISTIsrael: People with a recent COVID infection were six times more likely to develop Guillain-Barre than those without a recent infection, claims a...
